ArsenalBio Launches With $85 Million Series A Financing to Advance New Paradigm to Discover and Develop Immune Cell Therapies
Leading by example: how AquaBounty, Oxford Biomedica, and Berkeley Lights have successfully brought products to market
Renew Biopharma Announces Landmark Patent in Cannabinoid Biosynthesis; CEO to Speak Today at SynBioBeta